# Knowledge Assessment Report: LAB-012

**Experiment**: Independent Validation of the Information DNA Methodology
**Report Date**: 2026-07-19
**Methodology Version**: 2.2
**Domain**: Cross-Domain

---

## Executive Summary

LAB-012 performed independent validation of the Information DNA synthesis methodology developed in LAB-011. The experiment applied the methodology to 5 experiments not used in its development, attempting to falsify rather than confirm LAB-011 findings.

**Key Finding**: The methodology is **partially validated**. Confidence thresholds are domain-dependent, and domain independence claims require refinement.

---

## 1. Experiment Summary

| Phase | Status | Deliverable |
|-------|--------|-------------|
| Validation Runs | ✓ COMPLETE | 6 runs (LAB-002 through LAB-006) |
| Falsification Attempts | ✓ COMPLETE | 4 DNA units tested |
| DNA Synthesis | ✓ COMPLETE | 2 new DNA units |
| Comparison Analysis | ✓ COMPLETE | conclusions.md |
| Impact Assessment | ✓ COMPLETE | This report |

---

## 2. Statistics

| Metric | Value |
|--------|-------|
| Validation Experiments | 5 |
| Runs Completed | 6 |
| Observations | 60 |
| Evidence Items | 12 |
| Traceability Coverage | **100%** |
| DNA Units Validated | 4 |
| DNA Units Synthesized | 2 |
| Contradictions Found | 3 |
| Confirmations | 1 |

---

## 3. Knowledge Assessment Matrix

| Knowledge | SUPPORTS | CONTRADICTS | INCONCLUSIVE |
|-----------|----------|-------------|--------------|
| **KDE-001** | 3 | 2 | 1 |
| **KDE-002** | 6 | 0 | 0 |
| **KDE-003** | 2 | 3 | 1 |
| **TOTAL** | **11** | **5** | **2** |

---

## 4. Falsification Results

| LAB-011 DNA | Falsification Status | Evidence |
|-------------|---------------------|----------|
| SYN-METH-001 | **PARTIAL CONTRADICTION** | Domain assumptions violated |
| SYN-METH-002 | **NOT FALSIFIED** | Insufficient testing |
| SYN-METH-003 | **CONFIRMED** | 100% traceability |
| SYN-METH-004 | **CONTRADICTION** | 6 runs → HIGH, not ≥10 |

---

## 5. New DNA Synthesized

### SYN-VAL-001: Domain-Dependent Confidence

| Field | Value |
|-------|-------|
| **DNA ID** | SYN-VAL-001 |
| **Canonical Agreement** | Confidence thresholds are domain-dependent |
| **Supporting Observations** | 3 |
| **Deterministic Confidence** | MEDIUM |
| **Refines** | SYN-METH-004 |

### SYN-VAL-002: Systematic Weaknesses

| Field | Value |
|-------|-------|
| **DNA ID** | SYN-VAL-002 |
| **Canonical Agreement** | Methodology has systematic weaknesses |
| **Supporting Observations** | 4 |
| **Deterministic Confidence** | MEDIUM |
| **Documents** | SYN-METH-001 weaknesses |

---

## 6. Traceability Report

### Observation Coverage

| Metric | Value |
|--------|-------|
| Total Observations | 60 |
| With Evidence | 60 |
| Invalid | 0 |
| Coverage | **100%** |

### Evidence Coverage

| Metric | Value |
|--------|-------|
| Total Evidence Items | 12 |
| Supporting Observations | 60 |
| Unused | 0 |
| Coverage | **100%** |

---

## 7. Comparative Analysis

| Experiment | Domain | Runs | Confidence | CONTRADICTS | Traceability |
|-----------|--------|------|------------|-------------|--------------|
| LAB-002 | Software | 10 | MEDIUM | 2 | 100% |
| LAB-003 | Software | 10 | MEDIUM | 1 | 100% |
| LAB-004 | Creative | 10 | MEDIUM | 2 | 100% |
| LAB-005 | Creative | 20 | MEDIUM | 7 | 100% |
| LAB-006 | Engineering | 6 | HIGH | 0 | 100% |

**Key Pattern**: Engineering domains achieve HIGH confidence with fewer runs than other domains.

---

## 8. Implications

### For LAB-011 DNA

| DNA | Action Required | Rationale |
|-----|----------------|------------|
| SYN-METH-001 | REFINE | Add domain-specific validity conditions |
| SYN-METH-002 | KEEP | Not falsified; insufficient testing |
| SYN-METH-003 | KEEP | Fully validated |
| SYN-METH-004 | REFINE | Domain-dependent thresholds needed |

### For Governance

1. **Approve domain-specific threshold calibration**
2. **Add validity conditions to domain independence claim**
3. **Prioritize systematic weakness resolution**

---

## 9. Recommendations

### For Governance Consideration

1. **Refine Confidence Thresholds**
   - Add domain-specific calibration
   - Engineering (standards): 5-6 runs → HIGH
   - Software: 10 runs → MEDIUM
   - Creative: 10+ runs → MEDIUM

2. **Clarify Domain Independence**
   - Add validity conditions by domain
   - Document which criteria require interpretation

3. **Address Systematic Weaknesses**
   - Propose consolidation mechanism
   - Distinguish evidence types
   - Define reproducibility per domain

---

## 10. Final Assessment

### Success Criteria

| Criterion | Status |
|-----------|--------|
| Attempt falsification | ✓ PASS |
| Find contradictions | ✓ PASS (3 found) |
| Produce new DNA | ✓ PASS (2 synthesized) |
| Maintain traceability | ✓ PASS (100%) |
| Provide recommendations | ✓ PASS |

### Conclusion

**LAB-012 successfully challenged and refined LAB-011 findings.**

The methodology is **partially validated**:
- **Confirmed**: 9-field structure, traceability, evidence-based nature
- **Refined**: Confidence thresholds are domain-dependent
- **Challenged**: Domain independence claim
- **Extended**: Identified systematic weaknesses

---

**LAB-012 Status**: COMPLETE

**Confidence Level**: MEDIUM

**Reproducibility**: ESTABLISHED (methodology documented; validation reproducible)

---

## Appendix: Files Produced

| File | Purpose |
|------|---------|
| experiment.md | Experiment definition |
| impact.md | This report |
| conclusions.md | Final conclusions |
| comparison.md | LAB-011 vs LAB-012 comparison |
| unresolved.md | Unresolved observations |
| runs/RUN-001.md | LAB-002 validation |
| runs/RUN-002.md | LAB-003 validation |
| runs/RUN-003.md | LAB-004 validation |
| runs/RUN-004.md | LAB-005 validation |
| runs/RUN-005.md | LAB-006 validation |
| runs/RUN-006.md | Comparison analysis |
| evidence/references.md | Evidence index |
| dna/SYN-VAL-001.md | Domain-dependent confidence |
| dna/SYN-VAL-002.md | Systematic weaknesses |
